In Re Parmalat Securities Litigation

414 F. Supp. 2d 428, 2006 WL 317021
District Court, S.D. New York·Decided February 9, 2006·No. 04 MD 1653(LAK)·Published·Cited by 41 cases

Opinion

MEMORANDUM OPINION

KAPLAN, District Judge.

The plaintiffs in these consolidated class actions were investors in the securities of the international dairy conglomerate Parmalat Finanziaria S.p.A. and its subsidiaries and affiliates (collectively “Parmalat”). 1 They seek recovery from Parmalat’s officers, directors, accountants, lawyers, and banks under Sections 10(b) 2 and 20(a) 3 of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 4 thereunder.

In an opinion dated July 13, 2005 {“Parmalat IIP’), this Court dismissed the *431 First Amended Complaint (the “FAC”) to the extent it asserted claims against defendants Bank of America Corp. (“BAC”), Bank of America, N.A. (“BAÑA”), and Banc of America Securities Ltd. (“BASL”) (collectively, “BoA”). 5 Plaintiffs subsequently filed a Second Amended Complaint (the “SAC”), which adds a number of new allegations regarding BoA’s role in the alleged fraud. The action is before the Court on BoA’s motions to dismiss the SAC. 6

I. Background

A. Dismissal of the FAC

The FAC alleged that BoA (1) devised and implemented a number of deceptive transactions involving Parmalat in violation of Rule 10b-5(a) and (c), (2) misrepresented or omitted information about those transactions in violation of Rule 10b — 5(b), and (3) was liable as a controlling person under Section 20(a) for Rule 10b-5 violations committed by various BoA subsidiaries, agents, and employees.

In Parmalat III, this Court dismissed all three claims against BoA. It first rejected the Rule 10b-5(a) and (c) claim because plaintiffs had not alleged facts indicating that the transactions BoA devised and implemented actually were deceptive. As that opinion made clear,

“In each of these cases, what remains when the bluster is stripped away are financings and investments ... Any deceptiveness resulted from the manner in which Parmalat or its auditors described the transactions on Parmalat’s balance sheets and elsewhere. In entering into these transactions, [BoA] therefore did not use or employ a deceptive device or contrivance.” 7

Next, the Court dismissed plaintiffs’ Rule 10b~5(b) claims, concluding that BoA could not be held liable for alleged misrepresentations made by Parmalat and that claims based on alleged misstatements by BoA itself either were time-barred or pleaded with insufficient particularity. The Court concluded also that any alleged omissions by BoA were not actionable because plaintiffs had not alleged any basis for finding that BoA had a duty to disclose the information omitted. 8 The Section 20(a) claim was dismissed for want of a primary violation. 9

B. BoA’s Motion to Dismiss the SAC

The SAC asserts claims under Rule 10b-5(a) and (c), Rule 10b — 5(b), and Section 20(a) and adds a number of new allegations aimed at curing defects identified by the Court in Parmalat III. Most significantly, the SAC contains several pages of new allegations regarding three allegedly deceptive transactions: (1) a $300 million loan to Parmalat’s Brazilian subsidiary, Parmalat Empreendimentos e Administracao (“PA”) in December 1999, (2) the subsequent restructuring of the PA transaction through CUR Holdings, a special purpose vehicle allegedly controlled by BoA, and (3) the 2001 restructuring of a 1998 loan from BoA to Parmalat’s Venezuelan subsidiaries. It adds also allegations regarding BoA’s scienter, the BoA defendants’ control over various subsidiaries and employees, and defendant BASL’s contacts with this forum.

BoA argues that the SAC suffers from the same defects that doomed the FAC. Specifically, it contends that the SAC fails to (1) allege that any of the transactions *432 BoA participated in was deceptive, (2) allege that BoA made any actionable misrepresentations or omissions regarding the transactions, (3) plead facts giving rise to a strong inference of scienter, (4) state a claim under Section 20(a), and (5) allege facts supporting the exercise of personal jurisdiction over BASL.

Notably, plaintiffs concede for purposes of this motion that, under Parmalat III, the SAC fails to plead any actionable omissions or misrepresentations attributable to BoA and therefore does not state a claim under Rule 10b-5(b). Accordingly, this opinion will address only BoA’s remaining arguments.

II. Legal Standards

In deciding a Rule 12(b)(6) motion, the Court accepts as true the complaint’s well-pleaded factual allegations and draws all reasonable inferences in the plaintiffs favor. 10 Dismissal is inappropriate “unless it appears beyond doubt that the plaintiff can prove no set of facts in support of his claim which would entitle him to relief.” 11

III. Discussion

A. Rule 10b-5(a) and (c): Deceptive and Manipulative Acts and Devices

To state a claim under Rule 10b-5(a) and (c), a plaintiff must allege that the defendant (1) committed a deceptive or manipulative act (2) with scienter, (3) that the act affected the market for securities or was otherwise in connection with their purchase or sale, and (4) that defendants’ actions caused the plaintiffs’ injuries. 12

Although the heightened pleading requirements of the PSLRA do not apply to claims under Rule 10b-5(a) and (c), such claims must be pleaded with specificity under Rule 9(b). 13 Accordingly, a plaintiff alleging market manipulation in violation of Rule 10b-5(a) and (c) must specify, with particularity, “what manipulative acts were performed, which defendants performed them, when the manipulative acts were performed and what effect the scheme had on the securities at issue.” 14

Free access — add to your briefcase to read the full text and ask questions with AI

In Re Parmalat Securities Litigation, 414 F. Supp. 2d 428, 2006 WL 317021 (S.D.N.Y. 2006).

414 F. Supp. 2d 428 (In Re Parmalat Securities Litigation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Barnes v. Oldner
259 F. Supp. 3d 926 (E.D. Arkansas, 2017)
In re EZCorp, Inc. Securities Litigations
181 F. Supp. 3d 197 (S.D. New York, 2016)
Tarsavage v. CITIC Trust Co.
3 F. Supp. 3d 137 (S.D. New York, 2014)
Securities & Exchange Commission v. Goldstone
952 F. Supp. 2d 1060 (D. New Mexico, 2013)
Public Pension Fund Group v. KV PHARMACEUTICAL CO.
679 F.3d 972 (Eighth Circuit, 2012)
In re Stillwater Capital Partners Inc. Litigation
858 F. Supp. 2d 277 (S.D. New York, 2012)
In Re Tronox, Inc. Securities Litigation
769 F. Supp. 2d 202 (S.D. New York, 2011)